Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia.
about
Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic DrugsPositive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatmentSerotonergic hallucinogens as translational models relevant to schizophrenia.Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction.Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.Therapeutic potential of metabotropic glutamate receptor modulators.Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia.An important role for cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors.Localization of NAAG-related gene expression deficits to the anterior hippocampus in schizophreniaGroup II metabotropic glutamate receptors and schizophrenia.Glutamate receptor abnormalities in schizophrenia: implications for innovative treatments.The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatmentIn the grey zone between epilepsy and schizophrenia: alterations in group II metabotropic glutamate receptors.The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat.Neonatal exposure to MK-801 reduces mRNA expression of mGlu3 receptors in the medial prefrontal cortex of adolescent rats.Regulation of Akt and Wnt signaling by the group II metabotropic glutamate receptor antagonist LY341495 and agonist LY379268.
P2860
Q26744729-D7783F31-6C38-467B-882D-D3CC6D43A1D9Q26852047-383EAB88-46A3-4D1C-981F-46D424A8E901Q30427074-787853FB-5E16-49AA-931B-D2A836EE9A6BQ30619467-8D9248B0-0DFE-4950-A35E-B5EDF6012016Q33812982-0984D087-4C40-4517-BB65-7341BB40E547Q35186635-436B0F29-11FA-405A-8349-6C968170654BQ35778704-B2FD481E-548F-4FC5-8550-7D5D1156460EQ36515238-E7AD6727-8A3E-4C22-BA26-2C0E4710007FQ37198810-A725F407-4FB1-4D5C-9EC8-0DB5A7C4C2B8Q37199826-89B6B9DA-64A7-4DC1-B2B4-A0D498F2B088Q37473779-3006A279-280C-4092-B2B1-E12183D446FEQ38151703-8706AC77-21EC-4FDD-9701-1A794354E0BAQ38213709-76CF09BC-EF58-4187-9808-464772C82328Q38300355-333EC62E-0A1C-443D-8267-3869CDEEBC45Q46530393-30D328A3-508F-4CB1-9E4C-E5E8F47325A6Q54222076-0A72D2C2-16A2-4283-81FE-0BC80FF4461AQ54597890-75B47D95-1744-49AB-AF1C-56F438D0DA89
P2860
Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Metabotropic glutamate recepto ...... esencephalon in schizophrenia.
@en
Metabotropic glutamate recepto ...... esencephalon in schizophrenia.
@nl
type
label
Metabotropic glutamate recepto ...... esencephalon in schizophrenia.
@en
Metabotropic glutamate recepto ...... esencephalon in schizophrenia.
@nl
prefLabel
Metabotropic glutamate recepto ...... esencephalon in schizophrenia.
@en
Metabotropic glutamate recepto ...... esencephalon in schizophrenia.
@nl
P2093
P2860
P1476
Metabotropic glutamate recepto ...... mesencephalon in schizophrenia
@en
P2093
Cynthia L Bartus
Joel E Kleinman
Mary M Herman
Mayada Akil
Subroto Ghose
Thomas G Sherman
Thomas M Hyde
P2860
P304
P356
10.1080/00207450802330702
P577
2008-11-01T00:00:00Z